Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6266271 | Current Opinion in Neurobiology | 2016 | 7 Pages |
â¢Hyperexcitability of primary somatosensory afferents leads to neuropathic pain.â¢Nerve damage causes changes in the expression or function of numerous ion channels.â¢Many distinct channel changes are individually sufficient to cause hyperexcitability.â¢This degeneracy means that no single change is necessary for hyperexcitability.â¢Degeneracy helps explain why afferent hyperexcitability is refractory to treatment.
Neuropathic pain, which arises from damage to the nervous system, is a major unmet clinical challenge. Reversing the neuronal hyperexcitability induced by nerve damage is a logical treatment strategy but has proven frustratingly difficult. Here, we propose a novel explanation for that difficulty. Changes in several different ion channels are individually sufficient to cause hyperexcitability in primary somatosensory neurons. Despite offering multiple drug targets, this scenario is problematic: if multiple sufficient changes are triggered by nerve injury, then no single change is necessary for hyperexcitability. This so-called degeneracy compromises therapeutic interventions because drug effects on any one ion channel can be circumvented by changes occurring in other ion channels. Overcoming degeneracy demands a more integrative approach to drug discovery.
Graphical abstractDownload high-res image (147KB)Download full-size image